Clover Health Investments appointed former U.S. Senator Robert Torricelli and Dr. Brian J. Miller, M.D., M.B.A., M.P.H., to its Board of Directors, effective immediately. The appointments fill two previously disclosed vacancies and expand the board to nine directors. Torricelli will join the Audit Committee, while Miller will join the Clinical Committee. Torricelli brings 20 years representing New Jersey in the U.S. House of Representatives and U.S. Senate, experience on the Senate Finance Committee, and prior service on the boards of Clover’s insurance subsidiaries since 2022. Miller is a practicing hospitalist at Johns Hopkins Hospital, an Associate Professor of Medicine at the Johns Hopkins University School of Medicine, a Visiting Fellow at the Hoover Institution, Vice Chairman of the North Carolina State Health Plan’s Board of Trustees and a Medicare Payment Advisory Commission (MedPAC) commissioner. His regulatory background includes work with the Centers for Medicare & Medicaid Services, the U.S. Food and Drug Administration and the Federal Trade Commission. Clover said the directors will support its Medicare Advantage strategy, technology-enabled care model and oversight responsibilities.